EGFR and neoplasm: A study by Yong Serk Park et al. directly compared the tumor targeting ability of theranostic lipid NPs co-encapsulating quantum dots and paclitaxel, using either the anti EGFR antibody cetuximab or an undisclosed anti EGFR aptamer for targeting (immuno-QDM or aptamo-QDM, respectively) 173.